Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2008
12/03/2008EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/03/2008EP1996582A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-ý2-methyl-4,5-(methylenedioxy) phenylacetyl¨thiophene-3-sulfonamide, sodium salt
12/03/2008EP1996581A1 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments
12/03/2008EP1996578A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996577A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
12/03/2008EP1996574A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1458700B1 Substituted 2-phenyl benzofurans as estrogenic agents
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008CN101316844A Inhibitors of diacylglycerol acyltransferase (DGAT)
12/03/2008CN101316829A Oxadiazole derivatives with crth2 receptor activity
12/03/2008CN101316818A 3-amino-1-arylpropyl indoles and aza-substituted indoles
12/03/2008CN100439351C Benzofuran derivative
12/03/2008CN100439347C 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
12/03/2008CN100439346C Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
12/03/2008CN100439345C (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439338C Compositions, methods and kits pertaining to luminescent compounds
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100438911C Body weight gain inhibitor
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459566 1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds
12/02/2008US7459562 Monocyclic heterocycles as kinase inhibitors
12/02/2008US7459556 Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
12/02/2008US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459451 Pyrazolopyridine derivatives
12/02/2008US7459414 Herbicides
12/02/2008CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2302402C Stereoisomeric indole compounds, process for the preparation of the same, and use thereof
12/02/2008CA2248300C Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
11/2008
11/27/2008WO2008144380A1 Hepatitis c virus inhibitors
11/27/2008WO2008144305A1 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators
11/27/2008WO2008144062A1 Csf-1r inhibitors, compositions, and methods of use
11/27/2008WO2008143759A1 Pyrimidinones as casein kinase ii (ck2) modulators
11/27/2008WO2008143649A2 Novel oxazolidinone compounds as antiinfective agents
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008142550A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008141976A1 Diacylglycerol acyltransferase inhibitors
11/27/2008WO2008141731A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008WO2008035316A3 Phosphodiesterase inhibitors
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293783 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293720 Pyridinyl Sulfonamide Modulators of Chemokine Receptors
11/27/2008US20080293719 Pyridiazinone Derivatives for the Treatment of Tumours
11/27/2008US20080293718 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
11/27/2008US20080293717 Aryl sulfonamides
11/27/2008US20080293716 Benzamide rho-kinase (ROCK-1) inhibitors; N-(2-phenylethyl)-5-(4-pyridinyl)-2-thiophenecarboxamide
11/27/2008US20080293715 Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293706 Quinoxaline derivatives as pi3 kinase inhibitors
11/27/2008US20080293702 Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080292608 Compounds and Compositions as Ppar Modulators
11/27/2008US20080290329 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2687944A1 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2686951A1 Diacylglycerol acyltransferase inhibitors
11/27/2008CA2686267A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008CA2685858A1 Di-substituted amides for enhancing glutamatergic synaptic responses
11/26/2008EP1995242A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994030A1 Multi-cyclic compounds and method of use
11/26/2008EP1994017A2 Novel heterocyclic nf-kb inhibitors
11/26/2008EP1994016A2 5-phenyl-3-benzyl-oxazolidin-2-one derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994011A1 Sulfonyl benzimidazole derivatives
11/26/2008EP1993543A2 Novel crystalline forms of antidiabetic compounds
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP0945448B1 5-alkoxy-2(3h)-oxazolone compounds and process for the preparation thereof
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 647